3320 |
HEAT SHOCK PROTEIN 90 ALPHA FAMILY CLASS A MEMBER 1 |
HSP90AA1 |
EL52 |
HEL-S-65p |
HSP86 |
HSP89A |
HSP90A |
HSP90N |
HSPC1 |
HSPCA |
HSPCAL1 |
HSPCAL4 |
HSPN |
Hsp103 |
Hsp89 |
Hsp90 |
LAP-2 |
LAP2 |
140571 |
5253 |
ENSG00000080824 |
OTTHUMG00000171752 |
Lipopolysaccharide-associated protein 2 |
LPS-associated protein 2 |
HSP 86 |
Heat shock protein HSP 90-alpha |
Renal carcinoma antigen NY-REN-38 |
Heat shock 86 kDa |
BE0001120 |
P07900 |
HS90A_HUMAN |
2905 |
HEAT SHOCK PROTEIN HSP 90-ALPHA (HSP 86). [SOURCE:UNIPROT/SWISSPROT;ACC:P07900] |
Heat shock protein 90 alpha |
T18477 |
NP_005339 |
NM_005348 |
CancerCommons Reported Gene Name | HSP90 |
Interpro Short Name | ATPase-like_ATP-bd |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Domain |
Human Readable Name | DRUGGABLE GENOME |
Interpro Acc | IPR003594 |
Uniprot Status | Swiss-Prot |
Interpro Name | ATPase-like, ATP-binding domain |
Target Class | Miscellaneous |
Target Subclass | HSP90-like_chaperon |
Gene Biotype | PROTEIN_CODING |
GuideToPharmacology Gene Category Name | Heat shock proteins |
GuideToPharmacology Gene Category ID | 784 |
CELL SURFACE |
DRUGGABLE GENOME |
CLINICALLY ACTIONABLE |
TRANSCRIPTION FACTOR |
n/a |
Trial Name | SNX-5422 |
Novel drug target | Novel Target |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | alvespimycin hydrochloride, KOS-1022 (DMAG), NSC-707545 |
Specific Action of the Ligand | Inhibition |
inhibitor (inhibitory) |
Specific Action of the Ligand | Inhibition |
Endogenous Drug? | False |
Direct Interaction? | False |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | CNF1010 |
Mechanism of Interaction | Heat shock protein HSP90 inhibitor |
inhibitor (inhibitory) |
Trial Name | IPI-504 |
Novel drug target | Novel Target |
Mechanism of Interaction | Heat shock protein HSP90 inhibitor |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | IPI-493, oral retaspimycin |
inhibitor (inhibitory) |
Novel drug target | Novel Target |
Trial Name | XL888 |
Reported Cancer Type | Melanoma |
inhibitor (inhibitory) |
Mechanism of Interaction | Heat shock protein HSP90 inhibitor |
Direct Interaction | yes |
Trial Name | STA-9090 |
inhibitor (inhibitory) |
Reported Cancer Type | Lung |
agonist (activating) |
HSP90AA1 | Ensembl Gene Name |
Gene Biotype | PROTEIN_CODING |
3320 | Entrez Gene Id |
HSP90AA1 | Uniprot Gene Name |
HS90A_HUMAN | Uniprot Id |
Interpro Short Name | ATPase-like_ATP-bd |
Uniprot Evidence | 1: Evidence at protein level |
Interpro Type | Domain |
DRUGGABLE GENOME |
ENSG00000080824 | Ensembl Gene Id |
HSPCA | Display Id |
HEAT SHOCK PROTEIN HSP 90-ALPHA (HSP 86). [SOURCE:UNIPROT/SWISSPROT;ACC:P07900] | Description |
Human Readable Name | DRUGGABLE GENOME |
DRUGGABLE GENOME |
HSP90AA1 | Gene Symbol |
Target Class | Miscellaneous |
Target Subclass | HSP90-like_chaperon |
3320 | Entrez Gene ID |
CancerCommons Reported Gene Name | HSP90 |
5253 | HUGO Gene ID |
5253 | HUGO Gene Symbol |
heat shock protein 90 alpha family class A member 1 | HUGO Gene Name |
GuideToPharmacology Gene Category Name | Heat shock proteins |
GuideToPharmacology Gene Category ID | 784 |
HSP90AA1 | DrugBank Gene Name |
P07900 | UniProt Accession |
3320 | Entrez Gene Id |
3320 | Entrez Gene Id |
HSP90AA1 | MyCancerGenome Gene Symbol |
HSP90 | MyCancerGenome Reported Gene Name |
ENSG00000080824 | Gene Symbol |
HSP90AA1 | Ensembl Id |
DRUGGABLE GENOME |
HSPC1 | GENE_SYMBOL |
HSPCA | GENE_SYMBOL |
HSP90AA1 | GENE_SYMBOL |
Heat shock protein HSP 90-alpha | Gene Name |
P07900 | UniProt ID |
TRANSCRIPTION FACTOR |
HSP90A | GO Gene Synonym |
HSPC1 | GO Gene Synonym |
HSPCA | GO Gene Synonym |
CELL SURFACE |
HSP90AA1 | Gene Symbol |
CLINICALLY ACTIONABLE |
HSP90A | TTD Gene Abbreviation |
T18477 | TTD Target ID |
CLINICALLY ACTIONABLE |
CLINICALLY ACTIONABLE |